ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern China

He, Qiao; Zhou, Yi; Zhou, Jie; Zhao, Dan; Li, Luona; Li, Xianbing; Huang, Yecai; Wang, Qiuju; Zou, Haiming; Zhang, Kaijiong; Li, Yuping; Wang, Zuo; Deng, Yao; Meng, Fanping*; Ying, Binwu*; Yang, Mu*; Wang, Dongsheng*电子科技大学; 四川大学; 重庆大学
Clinica Chimica Acta2023-2-15DOI: 10.1016/j.cca.2023.117244
3被引8阅读
引用收藏
分享

摘要

Background: Numerous clinical studies have validated plasma EBV DNA as a reliable biomarker for nasopha-ryngeal carcinoma (NPC) screening, tumor load monitoring, and prognosis prediction in endemic regions. However, the clinical relevance of plasma EBV DNA as a biomarker for NPC in non-endemic areas is still unclear.Method: The pretreatment plasma EBV DNA of 1405 newly diagnosed NPC patients from three major regional hospitals in non-endemic areas were analyzed retrospectively. The medical records of 244 age-and gender-matched healthy individuals were reviewed. EBV DNA was detected using Polymerase Chain Reaction (PCR). Based on the baseline of 400 and 0 copies/mL, the distribution characteristics of the pretreatment EBV DNA load in different clinical stages and geographic regions were analyzed. The diagnostic value of pretreatment plasma EBV DNA for NPC with two baselines was evaluated using the ROC curve.Results: NPC patients had a significantly higher pretreatment EBV DNA level than healthy controls (P<0.001). Pretreatment EBV DNA was closely associated with clinical and TNM stages in non-endemic areas, as it was in endemic areas. However, when 400 copies/mL set as the detection baseline, the sensitivity and specificity for NPC diagnosis were 40.8 % and 100 %, respectively (AUC = 0.704, cut off = 200.5 copies/mL). This sensitivity was lower than that reported in endemic regions (41.5 % -97.1 %). Lower sensitivity may result in false negatives, missing diagnoses during NPC screening. Further investigation revealed that 39.7 % (558/1405) of NPC patients had detectable EBV DNA and S amplification curves. Optimizing the detection limit to 0 copies/mL, the sensitivity could be improved to 80.5 % (AUC = 0.901).Conclusions: In non-endemic areas, the clinical significance of plasma EBV DNA as a biomarker for NPC was restricted due to the low detection limit of 400 copies/mL. More efficient nucleic acid extraction and detection methods are needed to optimize the detection limit and increase the clinical application of plasma EBV DNA for NPC.

学科与关键词

关键词
NPCEBV DNABiomarkerNon-endemic areaSensitivity
相关
加载中…
  • Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
    Chan K C Allen; Woo John K S; King Ann; Zee Benny C Y; Lam W K Jacky; Chan Stephen L; Chu Sam W I; Mak Constance; Tse Irene O L; Leung Samantha Y M; Chan Gloria; Hui Edwin P; Ma Brigette B Y; Chiu Rossa W K; Leung Sing Fai; van Hasselt Andrew C; Chan Anthony T C; Lo Y M DennisN Engl J Med, 2017, 377(6): 513-522.
  • [The value of plasma EBV-DNA testing in high-risk group of nasopharyngeal carcinoma in the nasal endoscopy].
    He X F; Yu X; Ji M F; Fu M YLin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2017, 31(10): 770-773.
  • Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis.
    Peng Haiqin; Li Zhanzhan; Long Yujiao; Li Jiahui; Liu Zhiyuan; Zhou Rongrong2019.
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinica Chimica Acta
发表日期
2023-02-15
卷期
第 541 卷
页码
117244
DOI
10.1016/j.cca.2023.117244
语言
ENGLISH
成果收录
SCIE
资助标注
Sichuan Provincial Cadre Health Research Project [2021-YF05-01792-SN]; Support Project of Chengdu Science and Technology [2021-YF05-02064-SN, 2022YFS0006]; Sichuan Science and Technology Program [Chuan Gan Yan 2021-804]; [2021-YF05-02112-SN]

作者

  • H

    He, Qiao (第一作者)

    univ elect sci & technol china · sichuan canc hosp & inst

  • Z

    Zhou, Yi

    sichuan univ

查看全部 17 位作者收起作者
  • Z

    Zhou, Jie

    sichuan canc hosp & inst · univ elect sci & technol china

  • Z

    Zhao, Dan

    univ three gorges

  • L

    Li, Luona

    sichuan canc hosp & inst · univ elect sci & technol china

  • L

    Li, Xianbing

    sichuan canc hosp & inst · univ elect sci & technol china

  • H

    Huang, Yecai

    sichuan canc hosp & inst · univ elect sci & technol china

  • W

    Wang, Qiuju

    sichuan canc hosp & inst · univ elect sci & technol china

  • Z

    Zou, Haiming

    sichuan canc hosp & inst · univ elect sci & technol china

  • Z

    Zhang, Kaijiong

    sichuan canc hosp & inst · univ elect sci & technol china

  • L

    Li, Yuping

    sichuan canc hosp & inst · univ elect sci & technol china

  • W

    Wang, Zuo

    univ elect sci & technol china · sichuan canc hosp & inst

  • D

    Deng, Yao

    sichuan canc hosp & inst · univ elect sci & technol china

  • M

    Meng, Fanping (通讯)

    chong qing univ · univ three gorges

  • Y

    Ying, Binwu (通讯)

    sichuan univ

  • Y

    Yang, Mu (通讯)

    univ elect sci & technol china · sichuan canc hosp & inst

  • W

    Wang, Dongsheng (通讯)

    sichuan canc hosp & inst · univ elect sci & technol china

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417